Skip to main content

Doerfler Douglas's Form 4 filing

Maxcyte, Inc. (MXCT) · filed Jan 5, 2023

Accession no.
0001209191-23-001995
Filed
Jan 5, 2023, 5:39 PM ET
Trade date
Jan 3-5, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $152.4K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Doerfler DouglasCIK 0001874482Director, Officer (President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 3, 2023Common StockMOption exerciseAcquired+10,613$0.04+$424.52343,810Direct
Jan 3, 2023Common StockSSaleDisposed−10,613$5.13−$54,444.69333,197Direct
Jan 4, 2023Common StockMOption exerciseAcquired+9,153$0.04+$366.12342,350Direct
Jan 4, 2023Common StockSSaleDisposed−9,153$5.07−$46,405.71333,197Direct
Jan 5, 2023Common StockMOption exerciseAcquired+10,234$0.04+$409.36343,431Direct
Jan 5, 2023Common StockSSaleDisposed−10,234$5.04−$51,579.36333,197Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 3, 2023Common StockMOption exerciseDisposed−10,613$0.00$0434,467Direct
Jan 4, 2023Common StockMOption exerciseDisposed−9,153$0.00$0425,314Direct
Jan 5, 2023Common StockMOption exerciseDisposed−10,234$0.00$0415,080Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)